|
|
Celsis International plc - Comparative Business Analysis Snapshot
Business Description
Celsis International plc. The Group's principal activity is developing and supplying rapid diagnostic systems for detecting contamination in raw materials, in process and finished products. It also provides analytical testing services for customers, mainly focused on the pharmaceutical and biopharmaceutical industries. The Group also supplies in-vitro testing products for the screening of drug compounds early in the development process. The Group's operations is organised into three divisions. Rapid Detection provides rapid microbial detection systems to ensure safety and quality of pharmaceutical, personal care and beverage products. Analytical Services provides analytical testing ensuring the stability and chemical composition of pharmaceutical products. In Vitro Technologies provides products and services to the research and development departments allowing them to perform ADME-Tox in vitro testing.
Competitor Analysis
This analysis compares Celsis International plc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
